VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ABEV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ABEVAmbev S.A.
$2.80$43.7B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABEVBalance Sheet

Ambev S.A. (ABEV) Balance Sheet

26Y historyFree accessUpdated daily

Ambev maintains a fortress balance sheet with total debt of $2.9B and a debt-to-equity ratio of 0.03, though goodwill of $40.1B (29% of total assets) poses impairment risk if currency or market conditions deteriorate.

ABEV Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Total Current Assets40.47B43.88B54.16B36.56B37.82B38.63B35.34B27.62B25.33B24.72B23.89B28.31B20.73B20.47B16.26B14.68B12.91B10.3B9.29B7.88B6.8B4.93B5.38B5.5B5.59B4.68B2.69B
Cash & Short-Term Investments18.35B20.32B29.84B16.34B15.38B18.54B18.79B11.92B11.48B10.35B8.16B13.84B10.44B11.57B9.4B8.27B6.98B4.12B3.3B2.48B1.76B1.1B1.51B2.69B3.5B2.54B1.03B
Cash Only16.61B18.64B28.6B16.06B14.93B16.63B17.09B11.9B11.46B10.35B7.88B13.62B9.72B11.29B8.93B8.08B5.91B4.04B3.3B2.31B1.54B836.78M1.29B1.2B2.77B2.41B44.7M
Short-Term Investments1.74B1.68B1.24B277.2M454.5M1.91B1.7B14.6M13.4M0282.8M215.1M713M288.6M476.6M193.4M1.07B73.31M100K174.8M225.55M258.84M214.5M1.49B735.4M126.93M983.53M
Accounts Receivable8.25B10.23B9.85B9.18B8.2B4.79B4.3B8.57B7.03B7.96B4.37B4.17B4.61B4.37B2.47B4.17B3.98B4.64B3.91B3.44B2.23B2.22B1.48B1.6B768.1M802.54M794.99M
Days Sales Outstanding37.442.3140.242.0137.5624.0126.960.1551.0760.6634.9632.5444.1945.4727.7456.1257.57368.8764.1546.2250.6744.8567.3838.2744.8955.27
Inventory10.42B10.52B11.69B9.62B12.92B11B7.61B5.98B5.4B4.32B4.35B4.1B3.41B2.8B2.47B2.24B1.91B1.49B2.02B1.46B1.36B1.18B1.38B954.6M859.7M806.66M591.06M
Days Inventory Outstanding89.8689.5897.8389.36116.69112.6102.57100.66102.4387.4495.1393.1597.1688.1784.8690.882.3170.25102.0680.6383.4874.84105.4186.1693.987.4775.87
Other Current Assets3.47B2.09B2.78B1.43B1.31B4.29B4.64B1.16B1.42B1.51B7.01B5.98B2.27B1.78B536.5M400K51.8M60.18M67.8M102.7M1.14B687.27M776.3M258.8M420.8M536.67M246.95M
Total Non-Current Assets97.73B104.24B108.35B96.08B100.14B99.98B89.85B74.12B68.8B62.13B59.95B61.86B51.41B48.2B37.9B31.46B29.77B29.8B32.52B27.6B28.76B28.54B27.64B9.33B6.79B6.34B5.95B
Property, Plant & Equipment25.64B27.64B30.17B26.63B30.06B29.22B24.77B22.58B20.1B18.82B19.15B19.14B15.74B13.94B11.41B9.27B7.03B6.6B7.3B5.98B5.71B5.4B5.53B4.17B3.29B3.14B3.2B
Fixed Asset Turnover3.33x3.19x2.96x2.99x2.65x2.49x2.36x2.30x2.50x2.54x2.38x2.44x2.42x2.52x2.85x2.93x3.59x3.52x2.84x3.27x3.08x2.95x2.17x2.08x2.23x2.08x1.64x
Goodwill40.09B41.54B44.34B38B40.59B42.41B40.02B35.01B34.28B31.4B30.51B30.95B27.5B27.02B19.97B17.45B17.44B17.53B17.91B14.98B17.94B16.72B18.17B1.69B000
Intangible Assets10.57B11.04B12.53B10.04B9.22B8.69B7.58B6.31B5.84B4.67B5.25B5.09B3.75B3.21B2.94B1.76B1.82B1.93B2.49B00000626.9M617.56M614.7M
Long-Term Investments4.03B1.26B579.9M531.3M551M498.1M551.3M467M404.4M360M404.5M833.5M108.4M90.3M273.4M263.8M227.2M271.16M347.8M2.37B00147.4M25.4M000
Other Non-Current Assets11.88B11.32B20.73B12.9B13.28B14.42B12.37B6.81B6.16B6.65B2.37B3.09B2.92B2.29B1.89B18.5M2.15B2.1B100K1.23B1.55B4.39B1.57B1.62B1.31B1.42B1.14B
Total Assets138.21B148.11B162.51B132.64B137.96B138.6B125.2B101.74B94.13B86.85B83.84B90.18B72.14B68.67B54.16B46.14B42.68B40.1B41.81B35.48B35.56B33.47B33.02B14.83B12.38B11.03B8.64B
Asset Turnover0.62x0.60x0.55x0.60x0.58x0.53x0.47x0.51x0.53x0.55x0.54x0.52x0.53x0.51x0.60x0.59x0.59x0.58x0.50x0.55x0.50x0.48x0.36x0.59x0.59x0.59x0.61x
Asset Growth %-19.15%-8.86%22.51%-3.85%-0.46%10.71%23.05%8.09%8.38%3.59%-7.03%25%5.05%26.8%17.38%8.11%6.43%-4.09%17.86%-0.23%6.24%1.38%122.63%19.78%12.27%27.66%-
Total Current Liabilities39.62B45.6B49.39B41.01B40.54B38.87B33.48B25.01B25.21B29.07B28.77B30.14B21.82B17.35B15.65B14.42B10.55B8.49B10.54B8.4B6.84B5.05B8.77B4.72B2.83B3.41B2.7B
Accounts Payable20.73B22.6B25.22B23.2B24.33B25.08B19.34B15.07B14.05B11.85B10.87B11.83B8.71B8.01B6.69B11.3B4.66B3.65B3.35B2.62B1.39B1.06B1.05B199.1M789.1M571.16M579.14M
Days Payables Outstanding182.38192.41211.09215.47219.68256.69260.8253.73266.41239.99237.87268.92248.05252.57230.04458.44201.1172.08169.26145.0285.1367.6879.9917.9786.1961.9374.34
Short-Term Debt1.07B1.17B163.6M151.2M273.3M224.6M2.33B217.1M1.53B1.7B3.62B1.28B1.09B1.04B837.9M2.22B2.61B819.68M3.61B2.48B2.1B1.21B3.44B1.98B607.4M1.72B1.27B
Deferred Revenue (Current)000000000000000000000012.7M31M000
Other Current Liabilities6.45B14.25B4.03B5.28B4.42B2.97B2.3B2B2.22B7.18B7.59B11.17B5.45B3.28B1.39B101.6M571.1M769.3M602.6M909.1M1.16B2.33B4.27B917.6M1.11B1.12B855.01M
Current Ratio1.02x0.96x1.10x0.89x0.93x0.99x1.06x1.10x1.00x0.85x0.83x0.94x0.95x1.18x1.04x1.02x1.22x1.21x0.88x0.94x0.99x0.98x0.61x1.17x1.97x1.37x1.00x
Quick Ratio0.76x0.73x0.86x0.66x0.61x0.71x0.83x0.87x0.79x0.70x0.68x0.80x0.79x1.02x0.88x0.86x1.04x1.04x0.69x0.76x0.79x0.74x0.46x0.96x1.67x1.14x0.78x
Cash Conversion Cycle-55.12-60.52-73.06-84.11-65.43-120.09-131.33-92.92-112.92-91.9-107.77-143.23-106.69-118.93-117.44-311.52-61.29-28.841.67-0.2444.5857.8270.26135.5745.9870.4356.8
Total Non-Current Liabilities9.69B13.74B13.54B11.5B14.09B15.72B16.57B14.18B13.05B11.78B8.42B9.7B6.67B7.51B9.05B6.28B7.56B9.31B10.26B10.66B9.23B8.35B6.82B5.61B5.34B4.16B2.35B
Long-Term Debt1.88B2.22B324M391M454.3M267.2M338.4M697.8M850.7M2.83B1.73B2.29B1.61B1.85B2.32B1.89B4.16B6.46B7.07B7.53B7.46B5.99B4.37B4B3.88B2.85B927.48M
Capital Lease Obligations5.31B1.96B1.85B1.81B2.33B1.99B1.72B1.71B1.31B24.7M33M30.4M20M19.4M18.6M000000000000
Deferred Tax Liabilities18.88B6.94B5.01B3.32B3.73B3.21B3.04B2.37B2.42B2.33B2.33B2.47B1.74B2.1B1.37B1.11B1.02B1.11B821.1M697.2M405.7M0414.2M261.4M306.9M31.58M523.16M
Other Non-Current Liabilities3.96B2.62B6.35B5.97B7.58B10.25B11.47B9.4B8.46B6.59B4.32B4.91B3.3B3.55B5.34B3.28B2.38B1.74B2.37B2.27B1.21B2.36B1.95B1.34B1.15B1.28B899.74M
Total Liabilities49.32B59.34B62.93B52.5B54.63B54.58B50.05B39.19B38.26B40.85B37.19B39.84B28.5B24.86B24.7B20.7B18.11B17.8B20.8B19.05B16.07B13.4B15.6B10.33B8.17B7.58B5.05B
Total Debt2.95B5.35B3.45B3.5B3.85B3.13B4.79B3.06B4.1B4.57B5.4B3.6B2.72B2.91B3.17B4.11B6.77B7.28B10.68B9.87B9.57B7.2B7.81B5.98B4.49B4.57B2.19B
Net Debt-13.66B-13.29B-25.14B-12.56B-11.08B-13.5B-12.3B-8.84B-7.36B-5.79B-2.48B-10.02B-7B-8.63B-6.08B-4.03B862.1M3.24B7.38B7.56B8.03B6.36B6.52B4.78B3.36B2.16B2.15B
Debt / Equity0.03x0.06x0.03x0.04x0.05x0.04x0.06x0.05x0.07x0.10x0.12x0.07x0.06x0.07x0.08x0.12x0.28x0.33x0.51x0.53x0.49x0.36x0.45x1.33x1.07x1.32x0.61x
Debt / EBITDA0.10x0.18x0.12x0.14x0.16x0.14x0.23x0.15x0.19x0.22x0.26x0.16x0.15x0.17x0.20x0.31x0.58x0.69x1.17x1.12x1.73x1.77x2.01x2.00x2.11x1.69x4.15x
Net Debt / EBITDA-0.44x-0.46x-0.87x-0.50x-0.47x-0.60x-0.58x-0.43x-0.34x-0.28x-0.12x-0.46x-0.38x-0.49x-0.39x-0.31x0.07x0.31x0.81x0.86x1.45x1.56x1.68x1.60x1.58x0.80x4.06x
Interest Coverage8.50x8.14x9.13x30.86x28.73x10.89x37.63x31.96x11.60x3.50x10.15x4.99x22.05x23.77x24.91x25.27x17.06x7.08x5.59x5.70x5.80x4.41x3.35x26.15x3.43x--
Total Equity88.89B88.77B99.58B80.14B83.33B84.02B75.15B62.56B57.45B47.56B46.65B50.33B43.64B44.22B37.52B33.13B24.56B22.3B21.01B18.63B19.49B19.98B17.21B4.5B4.21B3.45B3.59B
Equity Growth %-26.58%-10.85%24.25%-3.82%-0.82%11.8%20.13%8.88%20.79%1.96%-7.32%15.33%-1.31%17.86%13.28%34.85%10.18%6.11%12.8%-4.43%-2.44%16.06%282.12%7.03%21.91%-3.81%-
Book Value per Share5.715.666.305.065.265.304.743.943.623.032.953.162.763.453.812.031.581.381.371.041.301.420.250.080.370.300.31
Total Shareholders' Equity88.31B87.91B98.64B78.97B81.96B82.64B73.82B61.28B56.25B45.59B44.83B48.33B42.22B42.99B25.4B23.09B24.36B22.02B20.79B18.12B19.27B19.85B17B4.31B4.13B3.36B3.08B
Common Stock58.31B58.28B58.23B58.18B58.13B58.04B57.9B57.87B57.71B57.61B57.61B57.61B57.58B57B249.1M000000003.12B3.05B00
Retained Earnings7.52B18.04B0000000-355.4M00000004.13B13.86B12.96B1.62B679.38M000913.71M522.17M
Treasury Stock0-2.95B0000-941.7M-955.2M00000000000-1.16B-940.7M-393.15M-329.99M-338.5M-180.6M-499.43M-10.53M
Accumulated OCI105.4B14.55B108.97B98.67B92.25B86.38B80.91B75.69B70.12B63.3B64.23B62.57B59.91B61.22B51.6M000012.47B14.49B14.56B12.59B1.52B1.26B01.95K
Minority Interest580M860.74M938.4M1.17B1.37B1.37B1.34B1.28B1.21B1.97B1.83B2B1.42B1.23B12.13B10.04B203M278.7M224.1M506.7M222.7M122.52M212.56M196.4M79.1M88.93M512.43M

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

FX and tax overhangs

Balance Sheet Contraction Amid FX Distortions

Total assets declined from $162.5B in 2024Q4 to $138.2B in 2026Q2, a 15% reduction, while equity fell from $98.6B to $88.3B, according to recent financial statements.

The sequential decline in total assets and equity appears driven by currency translation effects, particularly the weakening Brazilian Real and Argentine peso, which compress the reported USD values of local operations. Despite the nominal contraction, the balance sheet remains robust, with equity still covering over 60% of assets, suggesting the reduction is a translation artifact rather than a deterioration in underlying financial health. Investors should monitor whether this trend persists, as it may indicate ongoing FX headwinds that could mask true operational performance.

Minimal Leverage Masks Strategic Flexibility

Total debt stood at $2.9B in 2026Q2, with a debt-to-equity ratio of 0.03, reflecting a nearly debt-free balance sheet, as reported in the latest quarterly data.

The company's leverage is exceptionally low, with debt representing only about 2% of total assets, which provides substantial financial flexibility and minimal refinancing risk. The slight uptick in debt to $5.3B in 2025Q4 appears seasonal or related to working capital needs, but the overall trend is stable. This conservative capital structure suggests that Ambev is not reliant on external financing, and its cash reserves of $16.6B far exceed total debt, indicating a fortress-like balance sheet that can withstand economic shocks.

Asset Mix Reflects Distribution Moat

Goodwill and intangibles of $40.1B represent 29% of total assets, while net PPE of $25.6B is 18.5%, indicating a significant portion of the asset base is tied to acquisitions, per financial disclosures.

The substantial goodwill balance, largely from historical acquisitions, suggests that Ambev's asset base is heavily weighted toward intangible value rather than physical assets. This is consistent with a business model that relies on brand strength and distribution networks rather than heavy manufacturing infrastructure. However, the gradual decline in goodwill from $44.3B in 2024Q4 to $40.1B in 2026Q2 may indicate impairment charges or currency effects, which warrants monitoring for potential write-downs that could impact equity.

Equity Quality Supported by Retained Earnings

Retained earnings swung from $0 in 2024Q4 to $7.5B in 2026Q2, while equity remains above $88B, indicating strong profit retention, based on reported figures.

The volatility in retained earnings, which dropped to $3.0B in 2025Q1 and then rebounded, reflects the impact of dividend distributions and currency translation. Despite this, the overall equity base is substantial, and the company's ability to maintain high net margins (17.6%) suggests that internally generated capital is a key driver of equity growth. The lack of significant dilution from stock-based compensation, which averages only $104M per quarter, supports the quality of equity, as shareholder value is not being eroded by excessive issuance.

Liquidity Buffer Remains Adequate

The current ratio improved to 1.02 in 2026Q2 from 0.96 in 2025Q4, while cash reserves of $16.6B provide a strong buffer against short-term obligations, as per the latest balance sheet.

Although the current ratio is barely above 1.0, indicating that current assets only slightly exceed current liabilities, the company's massive cash position and minimal debt suggest that liquidity risk is low. The dip in the current ratio in 2025Q4 to 0.96 appears to be a seasonal anomaly, as it recovered in subsequent quarters. With cash alone covering over five times total debt, Ambev has ample liquidity to fund operations, invest in growth, and return capital to shareholders without facing financing constraints.

Goodwill Impairment Risk Lurks

Goodwill of $40.1B, representing 29% of total assets, is a significant balance sheet item that could be subject to impairment if currency or market conditions deteriorate, according to financial statements.

The large goodwill balance, primarily from past acquisitions, is a potential source of balance sheet distortion. If the Brazilian Real or Argentine peso continues to weaken, or if the company's market capitalization falls below book value, impairment charges could be triggered, reducing equity and net income. While there is no current indication of impairment, the persistent FX volatility and hyperinflation in Argentina create an environment where goodwill valuations are at risk. Investors should monitor management's impairment testing and any changes in segment performance that could signal a need for write-downs.

ABEV — Frequently Asked Questions

Quick answers to the most common questions about buying ABEV stock.

What are the total assets of Ambev S.A. (ABEV)?

As of 2025, Ambev S.A. (ABEV) had total assets of $148.11B including $43.88B in current assets.

How much debt does Ambev S.A. (ABEV) have?

Ambev S.A. (ABEV) carries total debt of $5.35B, offset by $20.32B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ambev S.A.?

Ambev S.A. (ABEV) has total shareholders' equity (book value) of $87.91B ($5.66 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ambev S.A.'s current ratio and liquidity?

Ambev S.A. (ABEV) reported a current ratio of 0.96x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.